Melinda Gooderham Selected Research

Melinda Gooderham Research Topics

Disease

52	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2024 - 11/2013
20	Atopic Dermatitis (Atopic Eczema) 05/2024 - 10/2015
7	Eczema 05/2024 - 10/2017
6	Psoriatic Arthritis 11/2023 - 10/2015
6	Infections 01/2023 - 01/2018
4	Erythema 05/2024 - 12/2012
4	Skin Diseases (Skin Disease) 12/2023 - 03/2018
3	Respiratory Tract Infections (Respiratory Tract Infection) 11/2023 - 11/2016
3	Inflammation (Inflammations) 01/2023 - 01/2020
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2022 - 01/2018
3	Neoplasms (Cancer) 06/2022 - 01/2018
3	Pruritus (Itching) 03/2021 - 10/2016
3	Rosacea (Acne Rosacea) 02/2020 - 12/2012
3	Injection Site Reaction 02/2018 - 11/2016
2	Alopecia Areata 01/2024 - 11/2023
2	Nasopharyngitis 01/2022 - 11/2016
2	Acne Vulgaris 01/2022 - 06/2019
2	Rheumatoid Arthritis 01/2020 - 01/2017
2	Communicable Diseases (Infectious Diseases) 12/2019 - 01/2019
2	Conjunctivitis 03/2018 - 10/2017
2	Necrosis 11/2017 - 11/2017
2	Asthma (Bronchial Asthma) 10/2017 - 10/2015
2	Chronic Disease (Chronic Diseases) 01/2017 - 11/2013
2	Basal Cell Carcinoma (Rodent Ulcer) 01/2017 - 02/2012
1	Edema (Dropsy) 05/2024
1	Seborrheic Dermatitis 01/2024
1	Synovitis 11/2023
1	Alopecia (Baldness) 11/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 09/2023
1	Exanthema (Rash) 02/2023
1	Pain (Aches) 02/2023
1	Cytopenia 06/2022
1	Headache (Headaches) 01/2022
1	Diarrhea 01/2022
1	Nausea 01/2022
1	Aphthous Stomatitis (Aphthous Ulcer) 01/2021
1	Oral Candidiasis (Thrush) 01/2021
1	Ulcer 01/2021
1	Chronic Urticaria 07/2020
1	Urticaria (Hives) 07/2020
1	Crohn Disease (Crohn's Disease) 02/2020
1	Ulcerative Colitis 02/2020
1	Skin Neoplasms (Skin Cancer) 02/2020

Drug/Important Bio-Agent (IBA)

13	ixekizumabIBA 04/2024 - 01/2015
9	Monoclonal AntibodiesIBA 04/2024 - 01/2015
9	Interleukin-17 (Interleukin 17)IBA 04/2024 - 01/2015
9	Immunoglobulin A (IgA)IBA 11/2023 - 09/2017
8	risankizumabIBA 01/2024 - 01/2017
8	InterleukinsIBA 11/2023 - 10/2015
8	CytokinesIBA 11/2023 - 10/2015
6	secukinumabIBA 02/2023 - 01/2015
5	apremilastIBA 01/2023 - 10/2015
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 10/2017
5	Adalimumab (Humira)FDA Link 01/2023 - 06/2017
5	dupilumabIBA 09/2021 - 10/2017
5	Janus Kinase InhibitorsIBA 01/2021 - 10/2016
4	RoflumilastIBA 01/2024 - 08/2020
4	Interleukin-13IBA 02/2023 - 10/2017
4	deucravacitinibIBA 01/2023 - 10/2018
3	lebrikizumabIBA 05/2024 - 01/2023
3	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 11/2023 - 08/2020
3	abrocitinibIBA 11/2023 - 01/2020
3	tralokinumabIBA 11/2023 - 01/2021
3	Ustekinumab (CNTO 1275)FDA Link 01/2023 - 01/2017
3	TYK2 Kinase (Tyrosine Kinase 2)IBA 01/2023 - 10/2018
3	Interleukin-23 (Interleukin 23)IBA 01/2021 - 01/2017
3	VaccinesIBA 12/2019 - 01/2019
3	brodalumabIBA 01/2019 - 01/2015
3	Interleukin-12 (IL 12)IBA 01/2018 - 10/2015
2	guselkumabIBA 02/2024 - 09/2023
2	frovatriptan (Allegro)FDA Link 01/2024 - 11/2023
2	Phosphotransferases (Kinase)IBA 01/2024 - 11/2023
2	bimekizumabIBA 01/2023 - 01/2021
2	omega-Chloroacetophenone (Mace)IBA 06/2022 - 02/2020
2	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 06/2022 - 04/2021
2	calcipotriene (calcipotriol)FDA LinkGeneric 06/2022 - 04/2021
2	Ivermectin (Mectizan)FDA Link 02/2020 - 09/2017
2	Doxycycline (Periostat)FDA LinkGeneric 02/2020 - 12/2012
2	Ointments (Pastes)IBA 09/2019 - 10/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 10/2015
2	tofacitinibIBA 12/2016 - 10/2016
2	Phosphodiesterase 4 InhibitorsIBA 01/2016 - 10/2015
1	SaltsIBA 11/2023
1	Immunologic Factors (Immunomodulators)IBA 09/2023
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Isotretinoin (Accutane)FDA LinkGeneric 01/2022
1	Oral ContraceptivesIBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2021
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 03/2021
1	tapinarofIBA 03/2021
1	Nystatin (Mycostatin)FDA LinkGeneric 01/2021
1	SuspensionsIBA 01/2021
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Omalizumab (Xolair)FDA Link 07/2020

Therapy/Procedure

29	Therapeutics 04/2024 - 01/2005
7	Biological Therapy 09/2023 - 01/2018
3	Phototherapy (Light Therapy) 04/2024 - 01/2018
1	Aftercare (After-Treatment) 07/2020